日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma

LOXHD1是尤文氏肉瘤的肿瘤融合调节抗原

Tatiana Blanchard ,Pouya Faridi ,Chong Xu ,Adham S Bear ,Reyaz Ur Rasool ,Grace Huang ,Terry C C Lim ,Rochelle Ayala ,Khatuna Gabunia ,Mei Ji ,Avery D Posey Jr ,John Scholler ,Irfan A Asangani ,Anthony W Purcell ,Gerald P Linette ,Carl H June ,Beatriz M Carreno

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors

靶向KRASG12V的天然TCR对人类实体瘤表现出良好的特异性和敏感性。

Adham S Bear ,Rebecca B Nadler ,Mark H O'Hara ,Kelsey L Stanton ,Chong Xu ,Robert J Saporito ,Andrew J Rech ,Miren L Baroja ,Tatiana Blanchard ,Maxwell H Elliott ,Michael J Ford ,Richard Jones ,Shivang Patel ,Andrea Brennan ,Zachary O'Neil ,Daniel J Powell Jr ,Robert H Vonderheide ,Gerald P Linette ,Beatriz M Carreno

A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy

一种用于控制和定量成像CAR-T细胞疗法的基因编码蛋白标签

Iris K Lee ,Nitika Sharma ,Estela Noguera-Ortega ,Maria Liousia ,Miren L Baroja ,Jean M Etersque ,Jonathan Pham ,Swarbhanu Sarkar ,Beatriz M Carreno ,Gerald P Linette ,Ellen Puré ,Steven M Albelda ,Mark A Sellmyer

Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

抗BCMA/CD19 CAR-T细胞联合早期免疫调节维持治疗用于对初始或后续治疗有反应的多发性骨髓瘤患者

Alfred L Garfall ,Adam D Cohen ,Sandra P Susanibar-Adaniya ,Wei-Ting Hwang ,Dan T Vogl ,Adam J Waxman ,Simon F Lacey ,Vanessa E Gonzalez ,Joseph A Fraietta ,Minnal Gupta ,Irina Kulikovskaya ,Lifeng Tian ,Fang Chen ,Natalka Koterba ,Robert L Bartoszek ,Margaret Patchin ,Rong Xu ,Gabriela Plesa ,Don L Siegel ,Andrea Brennan ,Anne Marie Nelson ,Regina Ferthio ,Angela Cosey ,Kim-Marie Shea ,Rachel Leskowitz ,Megan Four ,Wesley V Wilson ,Fei Miao ,Eric Lancaster ,Beatriz M Carreno ,Gerald P Linette ,Elizabeth O Hexner ,Regina M Young ,Dexiu Bu ,Keith G Mansfield ,Jennifer L Brogdon ,Carl H June ,Michael C Milone # ,Edward A Stadtmauer #

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

自体RNA电穿孔cMET靶向CAR T细胞静脉注射治疗黑色素瘤和乳腺癌患者的I期临床试验

Payal D Shah ,Alexander C Huang ,Xiaowei Xu ,Robert Orlowski ,Ravi K Amaravadi ,Lynn M Schuchter ,Paul Zhang ,Julia Tchou ,Tina Matlawski ,Amanda Cervini ,Joanne Shea ,Joan Gilmore ,Lester Lledo ,Karen Dengel ,Amy Marshall ,E John Wherry ,Gerald P Linette ,Andrea Brennan ,Vanessa Gonzalez ,Irina Kulikovskaya ,Simon F Lacey ,Gabriela Plesa ,Carl H June ,Robert H Vonderheide ,Tara C Mitchell

Expression of inducible factors reprograms CAR-T cells for enhanced function and safety

诱导因子的表达可对CAR-T细胞进行重编程,从而增强其功能和安全性。

Anže Smole ,Alexander Benton ,Mathilde A Poussin ,Monika A Eiva ,Claudia Mezzanotte ,Barbara Camisa ,Beatrice Greco ,Prannda Sharma ,Nicholas G Minutolo ,Falon Gray ,Adham S Bear ,Miren L Baroja ,Casey Cummins ,Chong Xu ,Francesca Sanvito ,Andrea Lang Goldgewicht ,Tatiana Blanchard ,Alba Rodriguez-Garcia ,Michael Klichinsky ,Chiara Bonini ,Carl H June ,Avery D Posey Jr ,Gerald P Linette ,Beatriz M Carreno ,Monica Casucci ,Daniel J Powell Jr

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

对突变型KRAS表位的生化和功能表征验证了该癌蛋白作为免疫靶向靶点的有效性。

Adham S Bear,Tatiana Blanchard,Joseph Cesare,Michael J Ford,Lee P Richman,Chong Xu,Miren L Baroja,Sarah McCuaig,Christina Costeas,Khatuna Gabunia,John Scholler,Avery D Posey Jr,Mark H O'Hara,Anze Smole,Daniel J Powell Jr,Benjamin A Garcia,Robert H Vonderheide,Gerald P Linette,Beatriz M Carreno

Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform

利用新型异种移植平台,对患者来源的肿瘤抗原特异性T细胞进行癌症免疫疗法的临床前评估

Gautam N Shenoy ,Christopher J Greene ,Maulasri Bhatta ,Miren L Baroja ,Jenni L Loyall ,Sathy V Balu-Iyer ,Raymond J Kelleher Jr ,Beatriz M Carreno ,Gerald P Linette ,Leonard D Shultz ,Richard B Bankert

Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens

免疫学无知是寡克隆 T 细胞对黑色素瘤新抗原反应的一个促成特征

Gerald P Linette, Michelle Becker-Hapak, Zachary L Skidmore, Miren Lorea Baroja, Chong Xu, Jasreet Hundal, David H Spencer, Weixuan Fu, Casey Cummins, Maya Robnett, Saghar Kaabinejadian, William H Hildebrand, Vincent Magrini, Ryan Demeter, Alexander S Krupnick, Obi L Griffith, Malachi Griffith, Elai

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity

产生 IL-12p70 的患者 DC 疫苗可引发 Tc1 极化免疫

Beatriz M Carreno, Michelle Becker-Hapak, Alexander Huang, Megan Chan, Amer Alyasiry, Wen-Rong Lie, Rebecca L Aft, Lynn A Cornelius, Kathryn M Trinkaus, Gerald P Linette